Clinical Trials Logo

Clinical Trial Summary

evaluate the influence of incomplete revascularization during the index hospitalization on in-hospital and long-term outcomes in STEMI patients undergoing PPCI in Assiut University heart hospital.


Clinical Trial Description

- Study groups: Patients will be divided into 2 groups

1. Group I: Complete revascularization was achieved by PPCI.

2. Group II: Complete revascularization was not achieved by PPCI.

- In hospital outcomes: All the patients will be reviewed for during hospital admission to record major acute cardiac events (MACE). Only the most serious event of major adverse cardiac events will be used to calculate the cumulative major adverse cardiac events per patient according to the following sequence: (death > heart failure > recurrent non-fatal MI > serious secondary arrhythmia necessitating DC shock> recurrent or refractory angina. MACE will be reported according to the standard definitions.(Tsai IT, et al.,2017)

- Long-term follow-up: The patients will be followed by telephone interviews for all-cause mortality, re-hospitalization by ACS, re-hospitalization by heart failure, planned and unplanned PCI or CABG. Long-term MACE will include: all-cause mortality, re-hospitalization by ACS, re-hospitalization by heart failure, unplanned revascularization. Patients who undergo planned revascularization later on after discharge will be followed till the date of revascularization for actual events and will be censored in Kaplan Meier Survival analysis. These patients will be included in a third group of staged late complete revascularization to be followed for the long-term MACE events starting from the planned revascularization procedure. ;


Study Design


Related Conditions & MeSH terms

  • Primary Percutaneous Coronary Intervention

NCT number NCT04332250
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date January 1, 2016
Completion date December 30, 2019

See also
  Status Clinical Trial Phase
Completed NCT02023983 - Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction N/A
Recruiting NCT01860079 - Early Discharge After Primary Percutaneous Coronary Intervention N/A
Completed NCT01152138 - Closed Versus Open Cells Stent for Acute Myocardial Infarction N/A
Recruiting NCT03406819 - Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI N/A
Recruiting NCT05510661 - Use of Export in Primary Percutaneous Coronary Intervention N/A
Completed NCT03146858 - Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study Phase 4
Not yet recruiting NCT01158846 - Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Phase 4
Active, not recruiting NCT03735719 - Biomarkers for Risk Stratification After STEMI